Markets:

Overview

News

Currencies

International

Treasuries

Humacyte, Inc. - Common Stock (NQ:HUMA)

0.6929 -0.0432 (-5.87%)

Streaming Delayed Price Updated: 11:45 AM EDT, Apr 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Humacyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

April 13, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Humacyte Inc (NASDAQ:HUMA) Reports Q4 Revenue Miss, Shares Drop Pre-Market ↗

March 27, 2026

Via Chartmill

The market is filled with gapping stocks in Monday's session. ↗

February 09, 2026

Via Chartmill

HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗

February 09, 2026

The company stated that its product, Symvess, is the only human-derived bioengineered blood vessel approved by the U.S. Food and Drug Administration.

Via Stocktwits

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

An Overview of Humacyte's Earnings ↗

August 08, 2025

Via Benzinga

Humacyte (HUMA) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Humacyte (HUMA) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Death Earnings

Humacyte Inc (NASDAQ:HUMA) Beats on EPS but Misses on Revenue in Q3 ↗

November 12, 2025

Humacyte (HUMA) missed Q3 revenue estimates but delivered a smaller-than-expected loss per share. The stock rose as investors focused on its pipeline progress toward key regulatory milestones.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 12, 2025

Via Benzinga

Insights Ahead: Humacyte's Quarterly Earnings ↗

November 11, 2025

Via Benzinga

BioMedNewsBreaks — Humacyte, Inc. (NASDAQ: HUMA) Announces $60 Million Registered Direct Offering of Common Stock and Warrants

October 15, 2025

Via Investor Brand Network

D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering

October 14, 2025

Via ACCESS Newswire

Top stock movements in today's session. ↗

October 07, 2025

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 07, 2025

Via Benzinga

Which stocks are moving on Tuesday? ↗

October 07, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Tuesday's session: gap up and gap down stocks ↗

October 07, 2025

The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 03, 2025

Via Benzinga

Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback ↗

September 18, 2025

Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Small caps rally 43% since tariff-driven selloff.

Via Benzinga

Topics ETFs Economy

Which stocks are experiencing notable movement on Monday? ↗

August 11, 2025

Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 11, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

August 11, 2025

Here are the top movers in Monday's session, showcasing the stocks with significant price changes.

Via Chartmill

Monday's session: gap up and gap down stocks ↗

August 11, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Humacyte Inc (NASDAQ:HUMA) Q2 2025 Earnings: Revenue Misses Estimates, Shares Drop 9.9% in Pre-Market ↗

August 11, 2025

Humacyte Inc (HUMA) Q2 2025 earnings show a revenue miss of 70%, with shares dropping ~9.9% pre-market. Hospital approvals grow, but commercial adoption lags.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 11, 2025

Via Benzinga

Humacyte Posts Q2 Revenue Miss ↗

August 11, 2025

Via The Motley Fool

Topics Intellectual Property

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday ↗

July 23, 2025

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Gold Falls 1%; ProKidney Shares Spike Higher ↗

July 08, 2025

Via Benzinga

Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday ↗

July 08, 2025

Via Benzinga

Gapping stocks in Tuesday's session ↗

July 08, 2025

In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.